The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Amneal Pharmaceuticals Inc shares valued at $1,571,723 were purchased by NIKITA SHAH on Nov 12 ’25. At $11.92 per share, NIKITA SHAH acquired 131,856 shares.
Also, Kiely John sold 32,000 shares, netting a total of over 295,360 in proceeds. Following the sale of shares at $9.23 each, the insider now holds 225,433 shares.
Before that, Kiely John had added 32,000 shares to its account. In a trade valued at $293,810, the Director bought Amneal Pharmaceuticals Inc shares for $9.18 each.
As published in their initiating research note from Goldman on June 06, 2025, Amneal Pharmaceuticals Inc [AMRX] has been a Buy and the price target has been revised to $12. Analysts at JP Morgan upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in late February. As of September 06, 2024, JP Morgan has increased its “an Underweight” rating to a “Neutral” for AMRX.
Analyzing AMRX Stock Performance
On last trading session, Amneal Pharmaceuticals Inc [NASDAQ: AMRX] plunged -3.19% to $11.52. The stock’s lowest price that day was $11.49, but it reached a high of $11.96 in the same session. During the last five days, there has been a drop of approximately -1.20%. Over the course of the year, Amneal Pharmaceuticals Inc shares have jumped approximately 25.22%. Shares of the company reached a 52-week high of $12.12 on 11/12/25 and a 52-week low of $6.68 on 04/10/25.
Support And Resistance Levels for Amneal Pharmaceuticals Inc (AMRX)
According to the 24-hour chart, there is a support level at 11.35, which, if violated, would cause prices to drop to 11.19. In the upper region, resistance lies at 11.82. The next price resistance is at 12.13. RSI (Relative Strength Index) is 61.46 on the 14-day chart, showing neutral technical sentiment.
Is Amneal Pharmaceuticals Inc subject to short interest?
Stocks of Amneal Pharmaceuticals Inc saw a sharp steep in short interest on 2025-10-31 dropping by -0.12 million shares to 5.58 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 5.69 million shares. A decline of -2.1% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.56 of the overall float, the days-to-cover ratio (short ratio) decline to 3.56.
Which companies own the most shares of Amneal Pharmaceuticals Inc (AMRX)?
In terms of Amneal Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 11 in the next 12 months, down nearly -7.56% from the previous closing price of $11.9. Analysts anticipate Amneal Pharmaceuticals Inc stock to reach 12 by 2025, with the lowest price target being 4. In spite of this, 1 analysts ranked Amneal Pharmaceuticals Inc stock as Buy at the end of 2025. On March 08, 2021, Goldman assigned a price target of “a Buy” to the stock and upgraded coverage with a $6.50.
